MDMA will be given in conjunction with structured psychotherapy in three single-dose psychotherapy sessions in a hospital setting over the course of 12 weeks. The overall objective of this study is to evaluate the risks, benefits, and feasibility of MDMA used in conjunction with manualized psychotherapy, on reduction of symptoms, or remission of PTSD, as evaluated by standard clinical measures, in a VA Healthcare System. The study will be conducted at the Loma Linda VA Healthcare System in California.
Clinical Trial Information:
Link: https://clinicaltrials.gov/ct2/show/NCT04264026?term=psychedelic&recrs=ab&draw=2